Repare Therapeutics stock is down as insiders flock to buy the $30-million RPTX dip

For the most part, biotech stocks have taken a beating this year, along with the broader market. The Nasdaq Biotechnology Index (INDEXNASDAQ: NBI) is down over 26% this year, while the S&P 500 is ...

Repare Therapeutics shares rise by 25% after it announced its collaboration deal with Roche

Repare Therapeutics Inc (NASDAQ: RPTX), a top clinical-stage precision oncology corporation, announced that it’s executed a collaboration and worldwide license deal with Roche for both the commerciali...